ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628665; 2) Community: the network communities that were significantly associated with the response to NSC 628665; 3) Molecule: the relationships between components within communities and NSC 628665; 4) MDR: the compounds that were significantly associated with the NSC 628665.

NSC Compound Enrichment Correlation
NSC 716951 Null 0.00457614317494024 0.41124527
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.00457614317494024 0.40481629
NSC 720447 Null 0.00457614317494024 -0.11373958
NSC 72961 8-Azadenosine 0.00457614317494024 0.25902941
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.00457614317494024 0.15291339
NSC 125845 Null 0.00479683626511385 0.4139521
NSC 131258 Null 0.00479683626511385 0.60600056
NSC 224131 N-Phosphonacetyl-L-aspartate 0.00479683626511385 0.36751098
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.00479683626511385 0.63121752
NSC 610458 Camptothecin Derivative 0.00479683626511385 0.70499675
Total:109  Current:21    [First] [Prev] [Next] [Last]